Article
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Neoplasia (New York, N.Y.) - 1 Feb 2016
Tiffen Jessamy, Wilson Stephen, Gallagher Stuart J, Hersey Peter, Filipp Fabian V
Abstract excerpt
The epigenetic modifier EZH2 is in the center of a repressive complex controlling differentiation of normal cells. In cancer EZH2 has been implicated in silencing tumor suppressor genes. Its role in melanoma as well as target genes affected by EZH2 are poorly understood. In view of this we have used an integrated systems biology approach to analyze 471 cases of skin cutaneous melanoma (SKCM) in The Cancer Genome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
